INDSWFTLAB Quarterly Results, Profit & Loss, Balance Sheet (INDSWFTLAB)

INDSWFTLAB quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

Ind-Swift Laboratories Ltd (INDSWFTLAB) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Ind-Swift Laboratories Ltd reported sales of ₹240 Cr, operating profit of ₹45 Cr (OPM 19%) and net profit of ₹34 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

INDSWFTLAB quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales129138153159151170191240
Expenses135147149151147149158195
Operating Profit-7-9474213345
OPM-5%-7%2.4%4.7%2.8%12%17%19%
Other Income16220151222-377
Interest10-27121-211
Depreciation67779888
Profit before tax-7230101016123343
Tax-16%4%17%22%42%-26%25%21%
Net Profit-52229810152534
EPS in Rs-0.9336.671.450.981.171.742.843.94
INDSWFTLAB profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,0391,2071,281574649753
Expenses8379781,029581602649
Operating Profit202229252-747104
OPM19%19%20%-1.2%7%14%
Other Income3774342923633
Interest969251310
Depreciation1315753243132
Profit before tax138758225851104
Tax117%45%28%3%15%-
Net Profit-2484212504384
EPS in Rs-0.368.0671.2441.324.979.69
Dividend Payout0%0%0%0%0%-
INDSWFTLAB balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital5969828787
Reserves8721,1041,2261,2971,387
Borrowings1733221820
Other Liabilities217232215271277
Total Liabilities1,1651,4381,5441,6731,771
Fixed Assets8273285304314
CWIP0001240
Investments111213312248281
Other Assets1,0479529471,1101,136
Total Assets1,1651,4381,5441,6731,771
INDSWFTLAB cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity150195-163-29-68
Cash from Investing Activity5-13-104-113-69
Cash from Financing Activity-141-18669972142
Net Cash Flow14-4431-695
Free Cash Flow137182-205-54-155
CFO/OP74%85%-65%131%-140%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit7485-65323-131
INDSWFTLAB ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days16015348105112
Inventory Days2882426145187
Days Payable11811352140185
Cash Conversion Cycle3302822110114
Working Capital Days2532342115156
ROCE7%13%20%3%5%